WO2023067519 - TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY
National phase entry:
Publication Number
WO/2023/067519
Publication Date
27.04.2023
International Application No.
PCT/IB2022/060058
International Filing Date
19.10.2022
Title **
[English]
TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY
[French]
COMPOSITIONS TOPIQUES ET PROCÉDÉS DE THÉRAPIE PHOTODYNAMIQUE
Applicants **
SUN PHARMACEUTICAL INDUSTRIES, INC.
2 Independence Way
Princeton, NJ 08540, US
Inventors
SANGHVI, Pradeep
2 Fleet Street
North Brunswick, New Jersey 08902, US
LUNDAHL, Scott
c/o DUSA Pharmaceuticals, Inc.
29 Dunham Road
Billerica, Massachusetts 01821, US
JIN, Xiaopin
3805 Periwinkle Crescent
Mississauga, Ontario L5N 6W8, CA
HADJIKEZIAN, Brenden B.
104 Chayna Crescent
Vaughan, Ontario L6A 0N1, CA
ZADYKOWICZ, Jerzy
3867 Arvona Place
Mississauga, Ontario L6T 1C1, CA
ABDALGHAFOR, Haydar
186 Provincial Place
Brampton, Ontario L6S 6C2, CA
HAQUE, Tasnuva
Apt. #2009, 64 Bramalea Rd
Brampton, Ontario L6T 2W8, CA
Priority Data
63/257,175
19.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2633 | |
| EPO | Filing, Examination | 23075 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 11110 |
Total: 37982 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Methods and topical compositions for the treatment of a dermatological disorder are provided. The topical composition includes 5-aminolevulinic acid, at least one penetration enhancer and at least one chelating agent. Further, methods and topical compositions for use in photodynamic therapy are disclosed, in which the topical composition is applied to the affected area of a patient for a period in the range of about 15 minutes to about 10 hours.[French]
L'invention concerne des procédés et des compositions topiques pour le traitement d'un trouble dermatologique. La composition topique comprend de l'acide 5-aminolévulinique, au moins un activateur de pénétration et au moins un agent chélatant. En outre, l'invention concerne des procédés et des compositions topiques destinés à être utilisés en thérapie photodynamique, la composition topique étant appliquée sur la zone affectée d'un patient pendant une période allant d'environ 15 minutes à environ 10 heures.